癌症研究
肿瘤微环境
免疫系统
细胞毒性T细胞
免疫疗法
癌症免疫疗法
生物
黑色素瘤
免疫学
CD8型
T细胞
趋化因子
免疫检查点
癌症疫苗
趋化因子受体
CXCL9型
抗原呈递
医学
下调和上调
抗原
CXCR3型
T细胞受体
免疫耐受
癌症
炎症
作者
Pan Wu,Junshang Ge,Xiangchan Hou,Hongke Qu,Jiawei Ouyang,Dan Wang,Tong Tong,Yi Meng,Qijia Yan,Lei Shi,Zhaojian Gong,Pan Chen,Bo Xiang,Ming Zhou,Ming Tan,WenLing Zhang,Zhaoyang Zeng,Wei Xiong
出处
期刊:Cancer Letters
[Elsevier BV]
日期:2026-03-27
卷期号:648: 218459-218459
被引量:6
标识
DOI:10.1016/j.canlet.2026.218459
摘要
Cancer immunotherapy harnesses and amplifies the host’s anti-tumor immune responses to eradicate malignant cells. Tumor neoantigens serve as ideal targets due to high specificity and immunogenicity. Circular RNA (circRNA), with a stable covalently closed structure, can be engineered as a novel vector for neoantigen expression. Here, we developed a circRNA-based vaccine encoding multiple melanoma neoantigens (circRNA MNA ). circRNA MNA significantly suppressed tumor growth in both prophylactic and therapeutic murine models and induced robust anti-tumor immunity. Mechanistically, using single-cell RNA sequencing, we elucidated the antitumor mechanisms and alterations in the tumor and immune microenvironment following vaccination. circRNA MNA immunization nearly eliminated the Ccl6 + Mel subcluster—highly active in chemokine signaling, leukocyte recruitment, and antigen presentation pathways. While residual Cdk1 + Mel and Cdhr4 + Mel subclusters exhibited downregulation of immune-response-related pathways. Furthermore, circRNA MNA vaccination reshaped myeloid cell composition, markedly increasing infiltration of monocytes/macrophages (Monocyte/MФ) with antitumor phenotypes, including classical inflammatory monocytes (Mono-Vcan), Macro-C1qc, and activated M1-like macrophages (Macro-Ifng). Chemokine signaling was enriched in Ccl6 + Mel and Monocyte/MФ clusters. Moreover, circRNA MNA enhanced T cell-mediated antitumor responses, elevating T cell receptor (TCR) clonotype diversity and expansion of TCR clonotypes especially in CD4 + effector (CD4 Eff) and CD8 + cytotoxic (CD8 Cyto) T cells. Notably, Tigit was identified as the most highly expressed checkpoint receptor in CD8 + exhausted T cells (CD8 Tex), and combining circRNA MNA with anti-TIGIT/PD1 blockade produced synergistic antitumor effects. Collectively, this study systematically elucidates the therapeutic potential and immune mechanisms of the neoantigen circRNA vaccine in melanoma, providing a mechanistic framework for developing personalized RNA vaccines and rational combination immunotherapies. • circRNA MNA suppresses tumor growth in prophylactic and therapeutic murine models. • circRNA MNA reprograms monocyte/MФ functions to promote melanoma cell elimination. • circRNA MNA vaccination boosts T and NK cell activity to enhance antitumor immunity. • circRNA MNA vaccine synergizes with ICB to cooperatively inhibit tumor growth in vivo.
科研通智能强力驱动
Strongly Powered by AbleSci AI